BrainsWay Ltd.

NASDAQ:BWAY

Medical - Devices

Healthcare
$8.98 +0.35%

+$0.05 today

Market cap
$352.22M
Beta
0.15
P/E (TTM)
61.7
EPS (TTM)
$0.23
52W Low $5.42High $17.35

Volume 0.15M

Average 0.15M

BWAY EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

BrainsWay Ltd.NASDAQ: BWAY

EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026

EPS (Diluted) growth accelerates

Q1 FY2026 EPS (Diluted) of $0.12 rose 500.0% year over year, ahead of the +188.8% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 14.3% from the prior quarter.

Context

  • EPS (Diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 2 analysts of $0.29 (-18.5%) for the fiscal year ending Dec 2026, a slowdown from the +300.0% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$0.12-14.3% QoQ
Last fiscal yearDec 2025
$0.36+300.0% YoY
LTMMar 2026
$0.35+188.8% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+500.0%+46.7%-453.3 pp
1 year+300.0%-18.5%-318.5 pp
3-year CAGR—+13.8%—
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
0.36 USD
Year-over-year change
+300.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How BWAY compares with its peers on the latest reported figures

  • BWAY's LTM Mar 2026 EPS (Diluted) of $0.35 is the highest of the 4 companies compared; the peer median is -$0.65.
  • Its year-over-year change of +188.8% is the highest of 4, against a peer median of +22.4%.
BWAY Competitors Peer median
EPS (Diluted) for BWAY and competitors
Company Period LTM YoY 3-year CAGR
BWAYBrainsWay Ltd.LTM Mar 2026$0.35 +188.8%—
STIMNeuronetics, Inc.LTM Mar 2026-$0.54 +58.8%—
NPCENeuroPace, Inc.LTM Mar 2026-$0.65 +22.4%—
HSDTSolana CompanyLTM Mar 2026-$33.93 -654.0%—
MOBIMobia Medical, Inc. Common Stock—— ——
Peer median (excluding BWAY) -$0.65+22.4%—

Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue29.66M27.18M31.79M41.02M52.23M
Cost of Revenue6.6M7.13M8.31M10.44M12.84M
Gross Profit23.06M20.05M23.48M30.58M39.39M
Gross Margin77.7%73.8%73.9%74.6%75.4%
Research & Development6.39M7.68M6.67M7.19M9.6M
Selling, General & Admin21.66M25.05M21.64M22M25.46M
Operating Expenses28.06M32.73M28.44M29.19M35.06M
Depreciation & Amortization1.69M1.53M1.34M1.77M1.54M
EBITDA(4.67M)(11.45M)(2.56M)5.36M11.46M
EBITDA Margin-15.8%-42.1%-8.1%13.1%21.9%
Operating Income(5M)(12.68M)(4.96M)1.39M4.32M
Operating Margin-16.9%-46.7%-15.6%3.4%8.3%
Interest Income225K1.11M2.17M2.48M5.64M
Interest Expense141K68K298K1.36M2.23M
Other Income / Expenses(1.42M)(351K)1.01M2.07M3.39M
Income Before Tax(6.42M)(13.03M)(3.95M)3.46M7.71M
Pre-Tax Margin-21.6%-48.0%-12.4%8.4%14.8%
Income Tax Expense43K315K251K538K77K
Net Income(6.46M)(13.35M)(4.2M)2.92M7.63M
Net Margin-21.8%-49.1%-13.2%7.1%14.6%
EPS (Basic)(0.21)(0.43)(0.13)0.090.40
EPS (Diluted)(0.21)(0.43)(0.13)0.090.36
Weighted Avg Shares31.15M32.98M33.16M33.97M19.08M
Weighted Avg Shares (Diluted)31.15M32.98M33.16M34.77M21.21M

BrainsWay Ltd.

NASDAQ:BWAY

Intrinsic Alpha fair value

Locked

Current Price

$8.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.